U.S. StrategyDelta 9 must clearly deliniate thier U.S. market strategy.
I have been following this company closely for a couple of years and to me their U.S. strategy isn't being communicated clearly. I thought it was about pod sales, and I know they have been trying there already, but I can't remember the last time we sold even a single pod anywhere.
We shouldn't expect a share price reaction to U.S. legalization if cannabis industry investors don't clearly see Delta 9 as a legitimate participant in that market.